Cargando…
Recombinant protein vaccines, a proven approach against coronavirus pandemics
With the COVID-19 pandemic now ongoing for close to a year, people all over the world are still waiting for a vaccine to become available. The initial focus of accelerated global research and development efforts to bring a vaccine to market as soon as possible was on novel platform technologies that...
Autores principales: | Pollet, Jeroen, Chen, Wen-Hsiang, Strych, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788321/ https://www.ncbi.nlm.nih.gov/pubmed/33421475 http://dx.doi.org/10.1016/j.addr.2021.01.001 |
Ejemplares similares
-
A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2
por: Thimmiraju, Syamala Rani, et al.
Publicado: (2023) -
Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate
por: Chen, Wen-Hsiang, et al.
Publicado: (2022) -
Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate
por: Chen, Wen-Hsiang, et al.
Publicado: (2017) -
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern
por: Pollet, Jeroen, et al.
Publicado: (2022) -
Coronavirus vaccine-associated lung immunopathology-what is the significance?
por: Bottazzi, Maria Elena, et al.
Publicado: (2020)